Function
Locations
Dehydrogenate acyl-CoA to 2-trans-enoyl-CoA, reducing O2 to H2O2.
Peroxisomal beta-oxidation chain-shortens the fatty acids that mitochondria cannot handle: very-long-chain fatty acids (VLCFAs, >=C22), 2-methyl-branched fatty acids (pristanic acid, from phytanic-acid alpha-oxidation), the C27 bile-acid intermediates di- and tri-hydroxycholestanoyl-CoA (DHCA/THCA, en route to cholic/chenodeoxycholic acid), and dicarboxylic acids from omega-oxidation. Each cycle removes two carbons as acetyl-CoA through the same four reactions, but with peroxisome-specific enzymes. Step 1 is an FAD-dependent acyl-CoA OXIDASE that passes electrons directly to O2 (making H2O2, not feeding the respiratory chain): ACOX1 acts on straight-chain (VLC) acyl-CoAs, and ACOX3 on 2-methyl-branched (pristanoyl) acyl-CoAs. Steps 2-3 (hydration then NAD+-dependent dehydrogenation) are performed by multifunctional proteins of opposite stereochemistry: the D-bifunctional protein HSD17B4 (the main enzyme for VLCFA, pristanic acid and bile-acid intermediates) and the L-bifunctional protein EHHADH (more important for medium-chain and dicarboxylic-acid substrates). Step 4, thiolytic cleavage to acetyl-CoA (or propionyl-CoA for branched substrates) plus a shortened acyl-CoA, is carried out by ACAA1 (straight-chain thiolase) and by the SCPx thiolase (encoded by SCP2, which also yields the sterol-carrier protein SCP2) for branched-chain and bile-acid substrates. The chain-shortened acyl-CoA re-enters the spiral. Inherited single-enzyme defects — ACOX1 deficiency (pseudo-neonatal adrenoleukodystrophy), D-bifunctional protein (HSD17B4) deficiency, EHHADH (renal Fanconi), and SCP2 deficiency — as well as the peroxisome-biogenesis Zellweger spectrum, cause VLCFA/pristanic-acid/bile-acid accumulation with severe neurological disease.
All recommended fields populated.
✗ none found
No MODULE:peroxisomal_beta_oxidation deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
5 complete review(s) · 0 with deep research · 0 missing review · 6 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| ACAA1 P09110 | ✓ | ✓ | ✗ |
| ACOX1 Q15067 | ✓ | 48/49 | ✗ |
| ACOX3 O15254 | ✓ | ✓ | ✗ |
| EHHADH Q08426 | ✓ | ✓ | ✗ |
| HSD17B4 P51659 | ✓ | ✓ | ✗ |
| SCP2 P22307 | ✓ | ✓ | ✗ |
Peroxisomal fatty-acid beta-oxidation (GO:0006635 + GO:0033540), grounded to six completed human gene reviews, all peroxisomal-matrix enzymes. STEP 1 (FAD oxidase, O2->H2O2): ACOX1 (Q15067, straight/VLCFA, GO:0003997; pseudo-neonatal ALD) + ACOX3 (O15254, 2-methyl-branched/pristanoyl, GO:0016402 — NB GO:0033812 is a THIOLASE not the oxidase) share PTHR10909. STEPS 2-3 (hydration+NAD+ dehydrogenation), opposite stereochemistry: D-bifunctional HSD17B4 (P51659 PTHR45024, GO:0080023 hydratase-2 + GO:0106386 (3R)-HAD; main enzyme for VLCFA/pristanic/bile-acid; D-BP deficiency + Perrault) and L-bifunctional EHHADH (Q08426 PTHR23309, GO:0004300 hydratase + GO:0003857 (3S)-HAD; medium-chain/dicarboxylic; PPARa-induced; renal Fanconi on mistargeting). STEP 4 (thiolysis): straight-chain ACAA1 (P09110 PTHR43853, GO:0003988) + branched/bile-acid SCPx (SCP2 gene, P22307 PTHR42870, GO:0050632 thiolase + GO:0120020 sterol transfer; SCP2 deficiency). The spiral iterates; acetyl-CoA/propionyl-CoA products and chain-shortened acyl-CoAs exit (via carnitine) to mitochondria. GO term ids/labels verified against the local go.db. This complements the mitochondrial FAO/ETF modules; the bile-acid branch feeds bile-acid synthesis (curated separately). Disorders: ACOX1, HSD17B4 (D-BP), EHHADH, SCP2 deficiencies; Zellweger spectrum (peroxisome biogenesis).
Dehydrogenate acyl-CoA to 2-trans-enoyl-CoA, reducing O2 to H2O2.
D-specific hydration + (3R)-dehydrogenation (main enzyme).
L-specific hydration + (3S)-dehydrogenation.
Thiolytic cleavage of straight-chain 3-oxoacyl-CoA (+ acetyl-CoA).
Thiolytic cleavage of branched/bile-acid 3-oxoacyl-CoA (+ sterol transfer).